Phosphorylcholine PC-mAb Effects in Subjects With Elevated Lipoprotein a

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 11, 2017

Primary Completion Date

March 19, 2018

Study Completion Date

July 3, 2018

Conditions

Arterial InflammationCardiovascular Diseases

Interventions

DRUG

PC-mAb

Monthly treatment for 3 months (4 administrations)

DRUG

Placebo

Monthly treatment for 3 months (4 administrations)

Trial Locations (2)

CTC Clinical Trial Consultants AB, Uppsala

Department of Vascular Medicine, Academic Medical Center, Amsterdam